首页> 外文期刊>Neuropathology: official journal of the Japanese Society of Neuropathology >Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells
【24h】

Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells

机译:1型胶原蛋白是CD133阳性胶质母细胞瘤细胞的潜在利基成分

获取原文
获取原文并翻译 | 示例
       

摘要

Cancer stem cells are thought to be closely related to tumor progression and recurrence, making them attractive therapeutic targets. Stem cells of various tissues exist within niches maintaining their stemness. Glioblastoma stem cells (GSCs) are located at tumor capillaries and the perivascular niche, which are considered to have an important role in maintaining GSCs. There were some extracellular matrices (ECM) on the perivascular connective tissue, including type 1 collagen. We here evaluated whether type 1 collagen has a potential niche for GSCs. Imunohistochemical staining of type 1 collagen and CD133, one of the GSCs markers, on glioblastoma (GBM) tissues showed CD133-positive cells were located in immediate proximity to type 1 collagen around tumor vessels. We cultured human GBM cell lines, U87MG and GBM cells obtained from fresh surgical tissues, T472 and T555, with serum-containing medium (SCM) or serum-free medium with some growth factors (SFM) and in non-coated (Non-coat) or type 1 collagen-coated plates (Col). The RNA expression levels of CD133 and Nestin as stem cell markers in each condition were examined. The Col condition not only with SFM but SCM made GBM cells more enhanced in RNA expression of CD133, compared to Non-coat/SCM. Semi-quantitative measurement of CD133-positive cells by immunocytochemistry showed a statistically significant increase of CD133-positive cells in Col/SFM. In addition, T472 cell line cultured in the Col/SFM had capabilities of sphere formation and tumorigenesis. Type 1 collagen was found in the perivascular area and showed a possibility to maintain GSCs. These findings suggest that type 1 collagen could be one important niche component for CD133-positive GSCs and maintain GSCs in adherent culture.
机译:癌症干细胞被认为与肿瘤的进展和复发密切相关,使其成为有吸引力的治疗靶标。 ni内存在各种组织的干细胞,维持其干性。胶质母细胞瘤干细胞(GSC)位于肿瘤毛细血管和血管周生境,这被认为在维持GSC方面具有重要作用。血管周围结缔组织上有一些细胞外基质(ECM),包括1型胶原。我们在这里评估了1型胶原是否对GSC具有潜在的利基性。胶质母细胞瘤(GBM)组织上1型胶原蛋白和GSCs标记之一的CD133的免疫组织化学染色显示,CD133阳性细胞紧邻肿瘤血管周围的1型胶原蛋白。我们用含血清培养基(SCM)或不含血清和某些生长因子(SFM)的非涂层(无涂层)培养人GBM细胞系,从新鲜手术组织T472和T555获得的U87MG和GBM细胞)或1型胶原蛋白涂层板(Col)。检查每种条件下作为干细胞标志物的CD133和Nestin的RNA表达水平。与Non-coat / SCM相比,Col条件不仅与SFM有关,而且与SCM有关,也使GBM细胞的CD133 RNA表达更加增强。通过免疫细胞化学对CD133阳性细胞进行半定量测量显示,Col / SFM中CD133阳性细胞的统计学显着增加。另外,在Col / SFM中培养的T472细胞系具有形成球体和肿瘤发生的能力。在血管周围区域发现了1型胶原蛋白,并显示了维持GSC的可能性。这些发现表明,1型胶原蛋白可能是CD133阳性GSC的重要生态位成分,并在贴壁培养中维持GSC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号